Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis.

Authors	Vittorio Mantero, Damiano Baroncini, Roberto Balgera, Clara Guaschino, Paola Basilico, Pietro Annovazzi, Mauro Zaffaroni, Andrea Salmaggi, Christian Cordano
Journal	Journal of neurology (J Neurol) Vol. 268 Issue 6 Pg. 2029-2030 (Jun 2021) ISSN: 1432-1459 [Electronic] Germany
PMID	32865629 (Publication Type: Letter)
Chemical References	Crotonates Hydroxybutyrates Nitriles Toluidines teriflunomide
Topics	COVID-19 Crotonates (adverse effects) Humans Hydroxybutyrates Multiple Sclerosis (drug therapy) Multiple Sclerosis, Relapsing-Remitting Nitriles SARS-CoV-2 Toluidines (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!